GW & Wade’s Allergan plc AGN Stock Holding History

GW & Wade’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-8,823	Closed	-$2.04M	–	249
2016 Q2	$2.04M	Buy	+8,823	New	+$2.03M	0.35%	66

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

GW & Wade's AGN Position: Q3 2016 in Review

GW & Wade sold out of Allergan plc (AGN) in Q3 2016, closing a stake of 8,823 shares — an estimated $2.04M sold.

GW & Wade first reported a position in AGN in Q2 2016 and held it in 1 quarter. The position peaked at $2.04M in Q2 2016. 1,105 funds tracked by Wall St. Rank hold AGN as of Q3 2016.

GW & Wade reported no remaining Allergan plc position as of Q3 2016 after selling out during the quarter.
GW & Wade sold 8,823 Allergan plc shares in Q3 2016, an estimated $2.04M.
GW & Wade first reported a position in Allergan plc in Q2 2016 and held it in 1 quarter.
GW & Wade's Allergan plc position peaked at $2.04M in Q2 2016.
1,105 funds tracked by Wall St. Rank held Allergan plc as of Q3 2016.

Based on GW & Wade's 13F filing for Q3 2016, filed 1 Nov 2016.